HIV-1 drug resistance and associated risk factors in antiretroviral therapy failure: a 2022–2024 surveillance in Huzhou, China
Characterizing acquired drug resistance (ADR) profiles among individuals experiencing antiretroviral therapy (ART) failure is critical for optimizing clinical management. This study aimed to delineate the HIV-1 drug resistance landscape, specific resistance-associated mutations, and epidemiological determi...